Pricing Log in Create free account

Organon & Co. (OGN) vs Scilex Holding Company (SCLX)

Organon & Co. and Scilex Holding Company are both Drug Manufacturers General companies. Organon & Co. is the larger, with a market value of $3.6B against $12.0M — 302.7× the size. Scilex Holding Company has negative trailing earnings, so its P/E is not meaningful; Organon & Co. trades at 17.3×. Organon & Co. grew revenue faster over the last twelve months: −3.21% against −28.6%. Organon & Co. has the higher net margin (3.49% vs −1,418.5%) and the higher return on invested capital (6.26% vs 0.00%). Across the 18 metrics below, Organon & Co. leads on 11 and Scilex Holding Company on 7.

Valuation

Metric OGN SCLX Drug Manufacturers General median
P/E 17.29 n/m 26.51
P/S 0.60 0.37 3.49
P/B 3.04 n/m 5.28
Price to free cash flow 6.35 n/m 21.67
EV/EBITDA 7.51 n/m 14.73
EV/Sales 1.76 2.93 4.15
Earnings yield 5.78% (2,877.70%) 2.41%
Free cash flow yield 15.75% (152.98%) 4.07%

Profitability

Metric OGN SCLX Drug Manufacturers General median
Gross margin 53.12% 55.50% 73.01%
Operating margin 13.63% (1,136.40%) 18.34%
Net margin 3.49% (1,418.45%) 7.31%
Free cash flow margin 9.38% (56.37%) 18.56%
Return on equity 20.30% 160.27% 5.80%
Return on assets 1.58% (265.83%) 2.28%
Return on invested capital 6.26% 0.00% 6.26%

Growth

Metric OGN SCLX Drug Manufacturers General median
Revenue growth (TTM) (3.21%) (28.55%) 6.72%
EPS growth (last fiscal year) (78.38%) (352.98%) 21.81%
Revenue growth, 5-year CAGR (0.99%) 5.13% 4.75%
Net income growth, 5-year CAGR (38.70%) 0.00% 0.00%

Health

Metric OGN SCLX Drug Manufacturers General median
Debt to equity 7.17 (0.26) 0.62
Current ratio 2.02 0.07 1.39
Net debt to EBITDA 5.62 (0.27) 1.15

Dividend

Metric OGN SCLX Drug Manufacturers General median
Dividend yield 0.58% — 2.32%
Payout ratio 0.11 — 0.59

Size

Metric OGN SCLX Drug Manufacturers General median
Market cap 3.62b 11.96m 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack